Table 2.

Risk group definitions

RiskCOG T-ALL risk group definitions
Standard risk M1 day 29 marrow; Day 29 MRD* <0.01%; CNS 1; no testicular disease; no steroid pretreatment 
Intermediate risk M1 or M2 day 29 marrow; day 29 MRD ≥ 0.01%; end-of-consolidation MRD < 0.1%; any CNS and testicular disease status; any steroid pretreatment status 
Very high risk M3 day 29 marrow or end-of-consolidation MRD ≥0.1% 
RiskCOG T-ALL risk group definitions
Standard risk M1 day 29 marrow; Day 29 MRD* <0.01%; CNS 1; no testicular disease; no steroid pretreatment 
Intermediate risk M1 or M2 day 29 marrow; day 29 MRD ≥ 0.01%; end-of-consolidation MRD < 0.1%; any CNS and testicular disease status; any steroid pretreatment status 
Very high risk M3 day 29 marrow or end-of-consolidation MRD ≥0.1% 

M1 marrow, less than 5% blasts; M2 marrow, 5-25% blasts; M3 marrow, more than 25% blasts by morphology; CNS1, less than 5 WBC/µL and no blasts in the CSF.

*

Central flow cytometry-based MRD.

Close Modal

or Create an Account

Close Modal
Close Modal